← Back to headlines
Sandoz Expands Biosimilars Business with Chinese Biotech Deal
Sandoz has announced an expansion of its biosimilars business through a new deal with a Chinese biotech company. This strategic partnership aims to strengthen Sandoz's presence in the global biosimilars market.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
FTC and Coalition of States Sue Amazon Over Alleged Ad Price Manipulation
57m ago
Instagram cracks down on unlabeled AI influencers amid Nepal flood disinformation
2h ago
EU Designates ChatGPT, Reddit, and Roblox Under Stricter Digital Rules
3h ago
Global Financial Watchdogs Warn of Systemic Risks From Artificial Intelligence
3h ago